Publication Name	World Journal of Hepatology
Manuscript ID	90325
Country	India

Received	2023-12-04 12:07
Peer-Review Started	2023-12-04 12:07
To Make the First Decision
Return for Revision	2024-01-05 23:42
Revised	2024-01-31 19:01
Second Decision	2024-04-09 03:15
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-09 06:49
Articles in Press	2024-04-09 06:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-11 02:51
Publish the Manuscript Online	2024-05-22 11:33

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Combined hepatocellular cholangiocarcinoma: A clinicopathological update
Manuscript Source	Invited Manuscript
All Author List	Mukul Vij, Fadl H Veerankutty, Ashwin Rammohan and Mohamed Rela
ORCID	Author(s) ORCID Number Mukul Vij http://orcid.org/0000-0003-0149-0294 Fadl H Veerankutty http://orcid.org/0000-0003-3167-0405 Ashwin Rammohan http://orcid.org/0000-0001-9528-8892 Mohamed Rela http://orcid.org/0000-0003-4282-4676
Funding Agency and Grant Number
Corresponding Author	Fadl H Veerankutty, Visiting Professor, MBBS, MS, Consultant Physician-Scientist, Surgeon, Comprehensive Liver Care Institute, VPS Lakeshore, NH 66, Nettoor, Maradu, Cochin 682040, India. write2drfadl@gmail.com
Key Words	Combined hepatocellular-cholangiocarcinoma; Immunotherapy; Nestin; Hepatocellular carcinoma; Cholangiocarcinoma; Liver cancer; Biomarker; Immune checkpoint inhibitors; Pathology; Genomic landscape
Core Tip	Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) represents a poorly understood rare primary liver tumor with a gruesome prognosis. Molecular and genetic characterization of this disease is vital for exploring newer treatment modalities to improve the survival of patients afflicted with this rare entity. In this review, we give an account of the recent developments in the pathology, diagnostic approach, and management of cHCC-CCA.
Publish Date	2024-05-22 11:33
Citation	<p>Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. <i>World J Hepatol</i> 2024; 16(5): 766-775</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i5.766

Full Article (PDF)	WJH-16-766-with-cover.pdf
Manuscript File	90325_Auto_Edited-YJP.docx
Answering Reviewers	90325-Answering reviewers.pdf
Audio Core Tip	90325-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90325-Conflict-of-interest statement.pdf
Copyright License Agreement	90325-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90325-Language certificate.pdf
Peer-review Report	90325-Peer-review(s).pdf
Scientific Misconduct Check	90325-Bing-Qu XL-2.jpg
Scientific Editor Work List	90325-Scientific editor work list.pdf
CrossCheck Report	90325-CrossCheck report.pdf